NCT01413802

Brief Summary

During thyroid surgery the laryngeal recurrent nerves (and for this reason the voice quality) are at risk. Therefore intra operative continuous neuromonitoring could help to prevent harm to these nerves. Electromyographic data (EMG values) are collected during surgery (1). In the postoperative follow-up period detailed voice analysis is performed (2): subjective auditive perceptive evaluation and videostroboscopy. Analysis and comparison of (1) and (2) will be performed in order to find out if we can find a predictive correlation between the EMG data (1) and the voice quality (2).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2011

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 8, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 10, 2011

Completed
22 days until next milestone

Study Start

First participant enrolled

September 1, 2011

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2012

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 5, 2013

Completed
Last Updated

December 29, 2022

Status Verified

December 1, 2022

Enrollment Period

6 months

First QC Date

August 8, 2011

Last Update Submit

December 28, 2022

Conditions

Keywords

Thyroid surgery

Outcome Measures

Primary Outcomes (3)

  • Detailed voice analysis to find a predictive correlation between the EMG data and the voice quality, after thyroid surgery.

    The primary outcome is to check if by continuous vagal nerve stimulation reversible damage to the recurrent laryngeal nerve can be foreseen, and therefore avoided. The detailed voice analysis that is used, consist of subjective auditive perceptive evaluation and videostroboscopy.

    1 week after surgery

  • Detailed voice analysis to find a predictive correlation between the EMG data and the voice quality, after thyroid surgery.

    The primary outcome is to check if by continuous vagal nerve stimulation reversible damage to the recurrent laryngeal nerve can be foreseen, and therefore avoided. The detailed voice analysis that is used, consist of subjective auditive perceptive evaluation and videostroboscopy.

    3 weeks after surgery

  • Detailed voice analysis to find a predictive correlation between the EMG data and the voice quality, after thyroid surgery.

    The primary outcome is to check if by continuous vagal nerve stimulation reversible damage to the recurrent laryngeal nerve can be foreseen, and therefore avoided. The detailed voice analysis that is used, consist of subjective auditive perceptive evaluation and videostroboscopy.

    3 months after surgery

Study Arms (1)

Thyroid surgery.

EXPERIMENTAL

Patients who undergo thyroid surgery during which intra operative continuous nerve monitoring will be used.

Procedure: Continuous nerve monitoring

Interventions

Continuous nerve monitoring is performed during thyroid surgery.

Thyroid surgery.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients (men/women) requiring thyroid surgery

You may not qualify if:

  • patients younger than 18 years, patients with preoperative vocal cord anatomical and functional anomalies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Onze Lieve Vrouw clinic Aalst

Aalst, Belgium

Location

University Hospital Ghent

Ghent, 9000, Belgium

Location

Related Links

Study Officials

  • Hubert Vermeersch, MD Phd

    University Hospital, Ghent

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 8, 2011

First Posted

August 10, 2011

Study Start

September 1, 2011

Primary Completion

February 28, 2012

Study Completion

March 5, 2013

Last Updated

December 29, 2022

Record last verified: 2022-12

Locations